424 related articles for article (PubMed ID: 15141383)
1. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
[TBL] [Abstract][Full Text] [Related]
2. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
3. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
[TBL] [Abstract][Full Text] [Related]
4. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
5. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
[TBL] [Abstract][Full Text] [Related]
6. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
Humar B; Guilford P
Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
[TBL] [Abstract][Full Text] [Related]
7. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
9. No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer.
Tanis PJ; Ten Kate FJ; van Lanschot JJ
J Surg Oncol; 2008 Mar; 97(3):294-6. PubMed ID: 18161866
[TBL] [Abstract][Full Text] [Related]
10. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers.
Lee AF; Rees H; Owen DA; Huntsman DG
Am J Surg Pathol; 2010 Jul; 34(7):1007-13. PubMed ID: 20534996
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
12. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
13. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
van Kouwen MC; Drenth JP; Oyen WJ; de Bruin JH; Ligtenberg MJ; Bonenkamp JJ; van Krieken JH; Nagengast FM
Clin Cancer Res; 2004 Oct; 10(19):6456-9. PubMed ID: 15475432
[TBL] [Abstract][Full Text] [Related]
14. Hereditary gastric cancer.
Carneiro F
Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
[TBL] [Abstract][Full Text] [Related]
15. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
16. Hereditary diffuse gastric cancer: diagnosis and management.
Blair V; Martin I; Shaw D; Winship I; Kerr D; Arnold J; Harawira P; McLeod M; Parry S; Charlton A; Findlay M; Cox B; Humar B; More H; Guilford P
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):262-75. PubMed ID: 16527687
[TBL] [Abstract][Full Text] [Related]
17. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].
Svrcek M
Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246
[No Abstract] [Full Text] [Related]
18. CDH1 associated gastric cancer: a report of a family and review of the literature.
Moran CJ; Joyce M; McAnena OJ
Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
[TBL] [Abstract][Full Text] [Related]
19. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
20. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
Cisco RM; Norton JA
Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
